This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Kyoto University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Sidonia Fagarasan: Innovator in Disease Treatment
Introduction
Sidonia Fagarasan is a prominent inventor based in Saitama, Japan. She has made significant contributions to the field of medical research, particularly in the area of disease treatment. Her innovative work focuses on the efficacy of therapies involving PD-1 signal inhibitors.
Latest Patents
Fagarasan holds a patent titled "Efficacy determination markers in disease treatment by PD-1 signal inhibitor." This invention provides markers for assessing the effectiveness of therapy with a PD-1 signal inhibitor at an early stage. The patent outlines the use of various biomarkers, including intestinal flora-related metabolites, energy metabolism-related metabolites, and amino acid metabolism-related metabolites, to predict the efficacy of such therapies.
Career Highlights
Fagarasan is affiliated with Kyoto University, where she conducts her research. Her work has garnered attention for its potential to improve treatment outcomes for patients undergoing therapy with PD-1 signal inhibitors.
Collaborations
She has collaborated with notable researchers in her field, including Tasuku Honjo and Kenji Chamoto. Their joint efforts contribute to advancing the understanding of immune responses and therapeutic strategies.
Conclusion
Sidonia Fagarasan's innovative research and patent contributions are paving the way for improved disease treatment methodologies. Her work exemplifies the critical role of inventors in advancing medical science and enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile